Global Maternal Health Conference

August 30-September 1

This international conference, held in New Delhi, India, was organized by the Maternal Health Task Force and the Public Health Foundation of India. Gynuity and colleagues presented on the topics of postpartum hemorrhage and preeclampsia.

Treatment of post-partum hemorrhage (PPH) with sublingual misoprostol versus oxytocin: Findings from two large double-blinded randomized non-inferiority trials.
D. Abbas (presented by B. Winikoff)

Barriers to magnesium sulfate use: A case study from Nagpur, India
S. Mundle (presenter), A. Barua, H. Bracken, J. Durocher, T. Easterling, B. Winikoff

Reducing the toll of unsafe abortion using simple medical technology:

• P. Smith: The potential of misoprostol alone for transitioning services: Lessons from Mexico City.

• A. Diop: Misoprostol as first line treatment of incomplete abortion: Introduction and expansion of existing services and implications for training.

• K. Lynd: Making outpatient services a reality: The role of home administration of mifepristone and misoprostol and a semi-quantitative pregnancy test in simplifying medical abortion provision.

• S. Hajri: Weighing the options: a randomized controlled trial of medical abortion with misoprostol only versus mifepristone plus misoprostol.

• H. Bracken: Expanding access late in the first trimester: The promise of out-patient mifepristone and misoprostol after 63 days.